Monalisa Dermal Fillers - Product Technology
Monalisa is a product of Korean based biotechnology pioneer Genoss Co Ltd. Genoss Co Ltd is one of the world’s leading enterprise in the field of medical device manufacturing, The primary mission set forth by GENOSS is to focus on delivering treatment solutions and promoting the well-being of its consumers and patients. GENOSS has demonstrated a strong commitment to R&D and to manufacture products with world-beating quality. GENOSS strictly fulfills and complies with the international quality regulations, including KGMP, ISO 13485 and ISO 9001. Furthermore, the CE mark and the FDA approval on each product confirm its conformity with all the legal requirements
Cross-Linking Technology
Hyaluronic Acid Foundation
Monalisa leverages the power of high-quality, non-animal sourced hyaluronic acid to replenish and restore the skin's natural HA levels. The use of HA in dermal fillers is widely recognized for its safety and compatibility with the human body, making it an excellent choice for facial rejuvenation treatments. The hyaluronic acid foundation in Monalisa Dermal Fillers ensures: Biocompatibility: As a biocompatible substance, HA minimizes the risk of adverse reactions, making Monalisa suitable for a wide range of patients with varying skin types. Hydration: HA's ability to attract and retain water molecules helps hydrate the skin from within, improving skin texture and elasticity.
Innovative Technology
Uniform Particle Size
Smooth Application: The uniform particle size ensures that the filler flows smoothly through the injection needle, making the procedure more comfortable for both the patient and the practitioner. Precise Results: With consistent particle size, the injector can accurately control the amount of filler used and achieve precise results, whether it's volumising the lips or filling in wrinkles. Natural Appearance: The even distribution of filler particles leads to a natural appearance. The filler integrates seamlessly with the surrounding tissues, avoiding any lumps or unevenness.
Cross-Linking Technology
Controlled Dissolution Rate
Longevity: The controlled dissolution rate of Monalisa fillers ensures that
the product lasts for an extended period. This means fewer touch-up
sessions, saving time and cost for patients.
Gradual Fading: As the filler gradually dissolves over time, the results
appear natural and subtle. There is no sudden loss of volume or abrupt
changes in appearance.
Flexibility for Future Treatments: A controlled dissolution rate allows
patients the flexibility to adjust their treatment plan as they age or their
aesthetic goals change.
Safety above all
High Safety Rate
BDDE is an essential chemical agent in the production of hyaluronic acid gels. This cross-linking agent plays a critical role in converting the liquid hyaluronic acid into a gel matrix that forms the foundation of many dermal fillers currently in the market. However, it is crucial to note that the residual amount of BDDE must be adequately regulated to ensure the safety of the product. In most countries, including the United States and the European Union, the maximum residual amount of BDDE allowed in hyaluronic acid gels is 2 parts per million (ppm). The MONALISA Filler has proven to be one of the safest options on the market. During quality control tests, BDDE was not detected in the Every MONALISA Filler, indicating that it is profoundly hygienic. As such, users can confidently turn to this product for their hyaluronic acid filler needs while enjoying unparalleled safety.
Hy-Brid Technology
High-Purity Material
At our Genoss manufacturing facility, we take great pride in producing high-quality dermal fillers made with our specifically formulated hyaluronic acid material. This material has been carefully appropriated for the utmost purity and safety for our customers. Not only do we prioritize safety in our materials, but we also abide by strict manufacturing processes. Our facility is certified with ISO 13485 and ISO 9001 to ensure that we meet the highest standards of quality for all of our products. Our unique Hy-BRID Technology sets our dermal fillers apart from others on the market. This technology creates ideal viscoelasticity, resulting in a natural-looking, smooth result that provides long lasting volume. Count on us to provide safe, effective, and lasting results.
Performance test
Better Viscoelasticity
Hy-BRID Technology is one of the latest innovative advancements in the world of dermal fillers. With this cutting-edge technology, MONALISA Dermal Fillers have unparalleled viscoelasticity and long-lasting volume. Unlike traditional dermal fillers, these products have been specially formulated to provide optimal results, leaving your skin looking flawless and rejuvenated. The Hy-BRID Technology used in the production of MONALISA Dermal Fillers and MONALISA Lidocaine is a unique blend of advanced ingredients that work synergistically to enhance the products' performance and efficacy. Whether you're looking to reduce the appearance of fine lines and wrinkles or restore lost volume, these dermal fillers are the perfect solution.
Monalisa Aesthetic Fillers
Outperforming Competitors
According to recent performance tests carried out on various dermal fillers in the market, Monalisa emerged as a top-performing contender. This remarkable product boasts superior viscoelasticity and volume properties, making it stand out from the rest. Further, the tests revealed that Monalisa has an extended lifespan compared to other fillers, adding value to its effectiveness. These performance qualities are essential in any dermal filler, and it comes as no surprise that Monalisa has become a popular choice for individuals seeking lasting, efficient results. Monalisa guarantees exceptional results leaving you looking and feeling your best.
GCWs
Genoss CW Purifying System
Genoss takes pride in the quality of our products, and that includes ensuring the purity of the materials we use in our monalisa dermal fillers.
Monalisa understand that our customers want to avoid harmful chemicals, and made sure that our monalisa fillers are free from any dangerous chemicals. To achieve this, Genoss use's a proprietary system called GENOSS's Complete Washing System. They have worked tirelessly to perfect this system.This process guarantees that our customers receive only the highest quality monalisa dermal fillers that provide excellent results.
Monalisa Purification
Quality Guarantee
Residue checks of BDDE are conducted for each individual lot item to ensure quality guarantee of our products. As the potential toxic effects of BDDE residue pose a safety concern, our thorough examination of each lot item aims to provide a secure, safe-to-use product. Through our quality control measures, we ensure that the gel performed cross-linker amount is under the limit of 2 parts per million residue. At MONALISA, we take great pride in our commitment to providing safe, reliable products to our customers. As such, we are pleased to report that our extensive testing has not found any traces of BDDE residue in our products.
Monalisa Dermal Fillers
High Purity Hyaluronic Acid Raw Materials
These fillers are made from Verified Filler Ingredients that have been tested to be safe and effective. The high molecule hyaluronic raw material contained in Monalisa Dermal fillers is of the highest quality and has undergone a strict refining process based on regulation standards to ensure that only the purest and safest raw material is used. Also have a High Molecule Hyaluronic Raw Material to further reduce any risk of adverse reactions. To further ensure the safety and efficacy of Monalisa Dermal fillers, each batch undergoes a thorough safety focused inspection process.
Quality Manufacturing
Our Refining Process
Our high-quality and reliable hyaluronic acid raw materials are the result of our proprietary technology and rigorous manufacturing processes that include incubation, fermentation/extraction, and refinement, ensuring our customers receive only the purest form of this amazing substance. Our commitment to quality and reliability is evident through our full automation process, which was implemented in 2018 and has greatly improved our production efficiency and consistency. Additionally, our unique cube-shaped crosslinked body enhances the efficacy of our hyaluronic acid.
Monalisa Dermal Fillers
Observation of surface structure
One of the crucial steps in the process of identifying biphasic HA fillers is analyzing their lattice structures. Irregular lattice structures are the notable characteristics of these types of fillers, and it is important to properly identify them in order to ensure their safe and effective use. Through the use of surface structure comparison tests, we have examined and analyzed the lattice structures present in three different types of biphasic HA fillers: Monalisa Lidocaine Hard, Restylane Lyft, and YVOIRE Volume Plus. By conducting these tests, we have gained valuable insights into the unique structural properties of each filler, which will ultimately help us to better understand their overall effectiveness and safety for patient use.
to ensure high safety
Low Crosslinking agents
MOD ( Degree of Modification %) Monalisa dermal fillers are designed with a focus on safety and effectiveness. The low crosslinking agents in these fillers ensure a balanced and controlled rate of bio-degradation, allowing for natural and long-lasting results without compromising safety. Ratio of cross-linked HA with BDDA (Cross linked BDDE + Pendant BDDE
Riessa Enterprise
Monalisa filler treatment area
Experience the transformative power of Monalisa, our cutting-edge soft tissue filler designed to reduce the appearance of fine lines, deep wrinkles, and volume loss. With its pure, cross-linked hyaluronic acid formulation containing 24mg/ml, Monalisa retains excellent volume effects for an extended period.
South Korean Medical device company
About GENOSS
Founded in South Korea in 2004, Genoss is a forward-thinking company with a bold vision to become the best medical device manufacturer in the world. Since its establishment in 2004, GENOSS has put enormous efforts to become the world’s leading medical device company. The primary mission set forth by GENOSS is to focus on delivering treatment solutions and promoting the well-being of its consumers and patients.
Exclusive Monalisa Distributor
About RIESSA
Riessa, was born at the junction of empowering individuals to embrace their timeless beauty. Riessa's essence is rooted in the philosophy that true beauty transcends age, and with our Monalisa dermal fillers, we aim to enhance and revitalize natural beauty at any stage of life. We the ONLY AUTHORIZED DISTRIBUTOR for MONALISA Dermal Fillers in INDIA.
Genoss & Riessa enterprise
Strengthening Innovation: Riessa Enterprise's Dynamic Partnership with Genoss
At Riessa, our journey has always been guided by a simple yet profound philosophy: to revolutionize the industry and empower individuals to feel confident and beautiful. We take a monumental step forward by joining forces with Genoss, a dynamic and forward-thinking entity that has been making waves in its own right. Genoss's commitment to advancing healthcare, biotechnology industry they specialize in, aligns perfectly with our ethos at Riessa. Together, our collaboration will amplify our capabilities and accelerate our impact on the lives of millions.
Monalisa Aesthetic Fillers
To Revoulutionize Indian Dermal Industry
Through this partnership, we are bringing together the expertise and experience of two visionary organizations. Genoss brings a wealth of knowledge and resources, complementing Riessa's prowess in the cosmetology industry. We firmly believe that this amalgamation of ideas, innovation, and talent will lead to a synergy that goes beyond what either of us could achieve individually. Our shared vision will steer us towards continued growth, innovation, and a profound impact on the cosmetology industry. Together, we will create a world where beauty knows no bounds, and every individual can embrace their uniqueness with confidence.
